Physician profile

Mark P Iltis

Family Medicine · Durant, IA

NPI 1659369353

$713.49

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$203.39
Food and Beverage$34.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bolton Medical INC $203.39 2023 Relay Thoracic Stent-Graft With Plus Delivery System
Cook Medical LLC $154.46 2019-2021
Boston Scientific Corporation $151.32 2022
Janssen Pharmaceuticals, INC $123.24 2021
Novo Nordisk INC $30.05 2022-2024
Getinge USA Sales, LLC $30.04 2022
Lilly USA, LLC $20.99 2023 Mounjaro

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark P Iltis

$713.49

in general payments reported 2019-2025

Years
2019-2024
Top company
Bolton Medical INC

https://glasscript.com/doctor/552621/mark-p-iltis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.